Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia.
Carolina MuguruzaBenito MorentinJ Javier MeanaStephen Ph AlexanderLuis F CalladoPublished in: Journal of psychopharmacology (Oxford, England) (2019)
The present findings reveal an imbalance in the expression and function of different elements of the endocannabinoid system in schizophrenia. This outcome highlights the relevance of the endocannabinoid system in the pathophysiology of schizophrenia and emphasises its elements as potential targets in the search for new therapeutic strategies.